Smruthi Organics Limited (SMRUTHIORG.BO)
INR 113.05
(-3.66%)
INR 113.05
(-3.66%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 111.28 Million INR | 117.79% |
| 2022 | 51.1 Million INR | 98.06% |
| 2021 | 25.8 Million INR | 145.07% |
| 2020 | -57.23 Million INR | -147.36% |
| 2019 | 120.85 Million INR | -48.61% |
| 2018 | 235.15 Million INR | -18.94% |
| 2017 | 290.08 Million INR | -4.45% |
| 2016 | 303.58 Million INR | -13.21% |
| 2015 | 349.79 Million INR | -9.39% |
| 2014 | 386.02 Million INR | -4.33% |
| 2013 | 403.48 Million INR | -4.62% |
| 2012 | 423.04 Million INR | 41.15% |
| 2011 | 299.71 Million INR | 397.34% |
| 2010 | 60.26 Million INR | -78.03% |
| 2009 | 274.28 Million INR | -31.75% |
| 2008 | 401.9 Million INR | -0.88% |
| 2007 | 405.47 Million INR | 15.91% |
| 2006 | 349.81 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 5.74 Million INR | -94.84% |
| 2023 Q2 | 88.18 Million INR | 404.42% |
| 2023 Q3 | 6.6 Million INR | -92.51% |
| 2023 Q1 | 17.48 Million INR | -65.79% |
| 2023 FY | 111.28 Million INR | 117.79% |
| 2023 Q4 | 111.28 Million INR | 1585.43% |
| 2022 Q3 | 38.36 Million INR | 127.48% |
| 2022 Q4 | 51.1 Million INR | 33.2% |
| 2022 Q1 | 5.66 Million INR | -78.06% |
| 2022 FY | 51.1 Million INR | 98.06% |
| 2022 Q2 | 16.86 Million INR | 197.94% |
| 2021 Q4 | 25.8 Million INR | -80.81% |
| 2021 Q2 | -25.39 Million INR | -115.73% |
| 2021 Q1 | 161.42 Million INR | 382.02% |
| 2021 Q3 | 134.43 Million INR | 629.29% |
| 2021 FY | 25.8 Million INR | 145.07% |
| 2020 Q4 | -57.23 Million INR | -140.69% |
| 2020 Q3 | 140.65 Million INR | 473.62% |
| 2020 FY | -57.23 Million INR | -147.36% |
| 2020 Q2 | -37.64 Million INR | 0.0% |
| 2019 Q1 | 41.55 Million INR | -82.33% |
| 2019 Q2 | 227.88 Million INR | 448.33% |
| 2019 Q4 | 120.85 Million INR | 286.03% |
| 2019 FY | 120.85 Million INR | -48.61% |
| 2019 Q3 | 31.3 Million INR | -86.26% |
| 2018 Q1 | 17.29 Million INR | -94.04% |
| 2018 Q4 | 235.15 Million INR | 1265.18% |
| 2018 Q3 | 17.22 Million INR | -92.64% |
| 2018 FY | 235.15 Million INR | -18.94% |
| 2018 Q2 | 234.15 Million INR | 1253.82% |
| 2017 Q3 | 19.5 Million INR | -93.03% |
| 2017 FY | 290.08 Million INR | -4.45% |
| 2017 Q4 | 290.08 Million INR | 1387.37% |
| 2017 Q1 | 16.2 Million INR | -94.66% |
| 2017 Q2 | 279.77 Million INR | 1626.84% |
| 2016 Q2 | 263.77 Million INR | 1521.49% |
| 2016 Q3 | 19.29 Million INR | -92.69% |
| 2016 Q1 | 16.26 Million INR | -95.35% |
| 2016 Q4 | 303.58 Million INR | 1473.37% |
| 2016 FY | 303.58 Million INR | -13.21% |
| 2015 Q4 | 349.79 Million INR | 2674.81% |
| 2015 Q3 | 12.6 Million INR | -95.98% |
| 2015 Q1 | 16.91 Million INR | -95.62% |
| 2015 Q2 | 313.6 Million INR | 1753.74% |
| 2015 FY | 349.79 Million INR | -9.39% |
| 2014 FY | 386.02 Million INR | -4.33% |
| 2014 Q4 | 386.02 Million INR | 1885.09% |
| 2014 Q3 | 19.44 Million INR | -94.88% |
| 2014 Q2 | 379.99 Million INR | 1429.97% |
| 2014 Q1 | 24.83 Million INR | -93.84% |
| 2013 Q2 | 408.69 Million INR | 4144.77% |
| 2013 Q4 | 403.48 Million INR | 2157.26% |
| 2013 FY | 403.48 Million INR | -4.62% |
| 2013 Q1 | 9.62 Million INR | -97.72% |
| 2013 Q3 | 17.87 Million INR | -95.63% |
| 2012 Q4 | 423.04 Million INR | 0.0% |
| 2012 Q2 | 274.49 Million INR | 0.0% |
| 2012 FY | 423.04 Million INR | 41.15% |
| 2011 FY | 299.71 Million INR | 397.34% |
| 2010 FY | 60.26 Million INR | -78.03% |
| 2009 FY | 274.28 Million INR | -31.75% |
| 2008 FY | 401.9 Million INR | -0.88% |
| 2007 FY | 405.47 Million INR | 15.91% |
| 2006 FY | 349.81 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | 83.415% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 4.266% |
| Bacil Pharma Limited | 569 Thousand INR | -19458.699% |
| Beryl Drugs Limited | 48.7 Million INR | -128.482% |
| Cian Healthcare Limited | 544.97 Million INR | 79.579% |
| Colinz Laboratories Limited | -64.3 Million INR | 273.07% |
| Concord Drugs Limited | 164.48 Million INR | 32.342% |
| Deccan Health Care Limited | -7.07 Million INR | 1672.767% |
| Gennex Laboratories Limited | -552.54 Million INR | 120.141% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -194.696% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 331.38% |
| Kerala Ayurveda Limited | 447.82 Million INR | 75.149% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 87.926% |
| Mercury Laboratories Limited | -26.72 Million INR | 516.361% |
| Panchsheel Organics Limited | -157.82 Million INR | 170.516% |
| Parmax Pharma Limited | 51.8 Million INR | -114.802% |
| Parnax Lab Limited | 787.61 Million INR | 85.87% |
| Patidar Buildcon Limited | 25.12 Million INR | -342.924% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -198.458% |
| Phaarmasia Limited | -4.89 Million INR | 2372.595% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 1073.657% |
| Sastasundar Ventures Limited | -297.24 Million INR | 137.44% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 349.393% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 289.958% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 89.37% |
| Sunil Healthcare Limited | 625.4 Million INR | 82.205% |
| Syschem (India) Limited | 3.53 Million INR | -3050.878% |
| Trident Lifeline Limited | 117.56 Million INR | 5.334% |
| Transchem Limited | -3.16 Million INR | 3618.463% |
| Tyche Industries Limited | -788.94 Million INR | 114.106% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -188.127% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 246.139% |
| Zenith Healthcare Limited | -25.45 Million INR | 537.165% |
| Zenotech Laboratories Limited | -196.85 Million INR | 156.533% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -341.389% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 74.222% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 1937.058% |
| MedPlus Health Services Limited | 8.67 Billion INR | 98.718% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 229.481% |
| Trimurthi Limited | -1.17 Million INR | 9545.68% |
| Zenlabs Ethica Limited | 139.54 Million INR | 20.249% |
| Makers Laboratories Limited | 172.59 Million INR | 35.519% |
| Lactose (India) Limited | 373.97 Million INR | 70.241% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 83.857% |
| Roopa Industries Limited | 216.01 Million INR | 48.481% |
| PANJON LTD. | -12.8 Million INR | 968.902% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -727.735% |
| Anuh Pharma Limited | -69.8 Million INR | 259.424% |
| Crestchem Limited | -1.45 Million INR | 7775.103% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 283.246% |
| PRAVEG LIMITED | -434.98 Million INR | 125.584% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 89.34% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 263.025% |
| Norris Medicines Limited | 214.86 Million INR | 48.204% |
| Denis Chem Lab Limited | -236.28 Million INR | 147.099% |
| Veerhealth Care Limited | -2.38 Million INR | 4766.205% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 114.053% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 80.521% |
| Godavari Drugs Limited | 530.02 Million INR | 79.003% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 1295.371% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 15.754% |
| Vivanza Biosciences Limited | 50.02 Million INR | -122.462% |
| Medi-Caps Limited | -3.21 Million INR | 3562.632% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 219.488% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 44.867% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 306.534% |
| Bharat Parenterals Limited | 1.48 Billion INR | 92.524% |
| BDH Industries Limited | -164.47 Million INR | 167.665% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -41.402% |
| Coral Laboratories Limited | -612.82 Million INR | 118.16% |
| Evoq Remedies Limited | 41.14 Million INR | -170.46% |
| Trinity League India Limited | -12 Thousand INR | 927508.333% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 92.023% |
| Natural Capsules Limited | 956.68 Million INR | 88.367% |
| Auro Laboratories Limited | 252.51 Million INR | 55.928% |